TargetMol
Cucurbitacin B has profound in vitro and in vivo antiproliferative effects against human pancreatic Y cells. It inhibited AKT signaling activation through up-regulation of PTEN. Cucurbitacin B is an effective inhibitor of HIF-1 and provide new perspectives into the mechanism of its anticancer activity. Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition […]
More Information
Supplier Page
Merimepodib
25 mg
| Purity Not Available
TargetMol
TargetMol
EXP-3174 is a potent AT1 antagonist (Kis: 0.57 nM, rat; 0.67 nM, human), producing a depressor response and vasodilatation. EXP3174, a metabolite of losartan, is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells.
More Information
Supplier Page
PHCCC
2 mg
| 99.31%
TargetMol
PHCCC is a Group I metabotropic glutamate receptor antagonist and a positive allosteric modulator of mGluR4. It also is a potent to antagonism for mGluR2 and mGluR8.
More Information
Supplier Page
SEA0400
1 mg
| Purity Not Available
TargetMol
SEA0400
2 mg
| Purity Not Available
TargetMol
SEA0400
25 mg
| Purity Not Available
TargetMol
TargetMol
Olumacostat glasaretil is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC). It has been used in trials studying the treatment of Acne Vulgaris.
More Information
Supplier Page
TargetMol
Olumacostat glasaretil is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC). It has been used in trials studying the treatment of Acne Vulgaris.
More Information
Supplier Page
HUHS015
2 mg
| Purity Not Available
TargetMol